Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
GMAB

Market Cap: $19.93B

GA

Genmab A/S

GMAB

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin39.92%

EBITDA Margin14.45%

EBIT Margin14.06%

Pre-tax Margin9.40%

Net Profit Margin8.17%

Earnings Yield3.96%

Valuation Multiples

Price / Book3.34

Price / Sales2.07

Price / Earnings25.36

PEG-0.30

Forward PEG0.53

EV / Sales2.46

EV / EBITDA17.01

EV / Operating Cash Flow26.54

EV / Free Cash Flow27.24

Price / Free Cash Flow22.91

Price / Operating Cash Flow22.30

Cash Flow & Capital

Free Cash Flow / Share$1.42

Operating Cash Flow / Share$1.46

Free Cash Flow Yield4.36%

Capex / Revenue0.24%

Capex / Operating Cash Flow2.59%

Capex / Depreciation0.25

Stock Compensation / Revenue1.62%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.46

Quick Ratio2.44

Cash Ratio1.32

Debt / Assets0.42

Debt / Capital0.47

Debt / Equity0.89

Long-Term Debt / Capital0.45

Debt / Market Cap25.76%

Net Debt / EBITDA2.71

Solvency Ratio0.13

Financial Leverage2.10

Efficiency & Working Capital

Asset Turnover0.77

Fixed Asset Turnover37.97

Inventory Turnover16.03

Receivables Turnover7.53

Payables Turnover0.00

Days Sales Outstanding48.45

Days Inventory Outstanding22.77

Days Payables Outstanding0

Operating Cycle71.22

Cash Conversion Cycle71.22

Working Capital Turnover6.31

Returns & Quality

Return on Equity13.58%

Return on Assets6.30%

Return on Invested Capital9.91%

ROCE11.71%

Return on Tangible Assets23.97%

Operating Return on Assets10.71%

Income Quality1.04

Tax Burden0.87

Interest Burden0.67

Balance Sheet & Intrinsic Metrics

Enterprise Value$23.7B

Invested Capital$11.14B

Working Capital$1.66B

Tangible Asset Value$-3.27B

Net Current Asset Value$-3.76B

Graham Number$167.58

Graham Net-Net-$6.66

Book Value / Share$9.71

Tangible Book Value / Share-$5.33

Cash / Share$2.45

Financial Health Scores

Piotroski Score5

Altman Z-Score12.96

Revenue$4.13B

EBIT$1.18B

Market Cap$127.55B

Working Capital$1.66B

Retained Earnings$4.42B

Total Assets$12.52B

Total Liabilities$6.56B